Hangzhou DAC Biotech Co., Ltd

Chine

 
Quantité totale PI 104
Rang # Quantité totale PI 12 540
Note d'activité PI 2,7/5.0    65
Rang # Activité PI 10 987
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

49 1
28 1
24 1
0
 
Dernier brevet 2024 - Targeted treatment of prostate c...
Premier brevet 2012 - Conjugates of cell binding molec...
Dernière marque 2020 - TRUMDACIN
Première marque 2020 - TRUMDACIN

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention An antibody-drug conjugate having two or more functional small molecule compounds for enhanced tr...
2023 Invention Targeted treatment of prostate cancers and other tumors by an antibody-drug conjugate. Provided h...
Invention A conjugate of a tubulysin analog with branched linkers. Described is a conjugation of a tubulys...
Invention Conjugate of a tubulysin analog with branched linkers. Described is a conjugation of a tubulysin...
2022 Invention Specific conjugation for an antibody-drug conjugate. Provided herein is a process for preparing a...
Invention Bcma monoclonal antibody and the antibody-drug conjugate. Provided is an antibody and an antibody...
Invention Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of mak...
2021 Invention Specific conjugation of an antibody. Provided herein is a process for preparing a homogeneous con...
Invention Conjugation of a cytotoxic drug with bis-linkage. A conjugation of a cytotoxic drug to a cell-bi...
Invention Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such ...
Invention Conjugates of cell-binding molecules with cytotoxic agents. A conjugate of a potent cytotoxic age...
2020 P/S Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparatio...
P/S Pharmaceutical preparations; chemico-pharmaceutical preparations; drugs for medical purposes; ch...
P/S Pharmaceutical preparations, namely, for the treatment of cancers and immunological disorders, na...
Invention Conjugates of a cell-binding molecule with camptothecin analogs. This invention relates to conju...
Invention Conjugates of a cell-binding molecule with camptothecin analogs. Provided are conjugates of campt...
Invention A formulation of a conjugate of a tubulysin analog to a cell-binding molecule. A formulation of ...
Invention A formulation of a conjugate of a tubulysin analog to a cell-binding molecule. A formulation of c...
Invention Conjugates of cell binding molecules with cytotoxic agents. 13 are as defined herein, can be used...
2019 Invention Conjugates of tubulysin derivatives and cell binding molecules and methods of making. The presen...
Invention Conjugates of tubulysin derivatives and cell binding molecules and methods of making. Involved is...
Invention Cell-binding molecule-tubulysin derivative conjugate and preparation method therefor. Involved is...
Invention A conjugate of a cytotoxic agent to a cell binding molecule with branched linkers. The present i...
Invention A conjugate of a cytotoxic agent to a cell binding molecule with branched linkers. Provided is a ...
Invention A conjugate of an amanita toxin with branched linkers. Provided herein is the conjugation of an ...
Invention A conjugate of an amanita toxin with branched linkers. Provided herein is the conjugation of an a...
2018 Invention A conjugation linker containing 2,3-diaminosuccinyl group. The present invention relates to a co...
Invention Conjugation linkers containing 2,3-diaminosuccinyl group. Provided is a conjugate of a cytotoxic ...
Invention A cross-linked pyrrolobenzodiazepine dimer (pbd) derivative and its conjugates. The present inve...
Invention Cross-linked pyrrolobenzodiazepine dimer (pbd) derivative and its conjugates. A novel cross-linke...
2017 Invention Conjugate of a tubulysin analog with branched linkers. The present invention relates to the conju...
2016 Invention Derivatives of amanita toxins and their conjugation to a cell binding molecule. 10, X, L, m, n an...